SELF: How to prevent and treat acne of the face
UC physician helps explain how different areas of the face are susceptible to acne
Dr. Katherine Baquerizo Nole, assistant professor of dermatology at the University of Cincinnati, lends her dermatolgical expertise to SELF magazine. The article explains how acne is the result of pores getting clogged with an excess of oil, dirt and dead skin. There are also plenty of environmental, behavioral and internal factors that can make you more prone to breakouts in specific regions of your face.
There are easy ways to make acne prevention part of your daily routine and the article takes a closer look at the major areas where face acne shows up — and what might be causing it.
Nole is one of two experts cited in the article which focuses on the forehead, nose, cheek and chin and general ways to prevent and treat those areas.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.